Where can I buy vivo shares?
Get the latest Meridian Bioscience, Inc. (VIVO) stock news and headlines to help you in your trading and investing decisions.
Does Meridian Bioscience (vivo) stock pay dividends?
Apr 24, 2022 · Their forecasts range from $30.00 to $30.00. On average, they expect Meridian Bioscience's share price to reach $30.00 in the next twelve months. This suggests a possible upside of 21.0% from the stock's current price. View analysts' price targets for Meridian Bioscience or view top-rated stocks among Wall Street analysts.
Are healthcare stocks right for long-term investors?
Compare VIVO Stock to Peers. Symbol Last Price Market Cap % Δ 1 Yr % Δ 5 Yr; VIVO. Meridian Bioscience $24.78 $1B 27.6% 71.7% TDOC. Teladoc Health $33.57 ...
See more
VIVO Valuation Summary. VIVO's price/sales ratio is 2.9; this is 74.45% lower than that of the median Healthcare stock. VIVO's price/earnings ratio has moved up 21.3 over the prior 243 months. Over the past 243 months, VIVO's EV/EBIT ratio has gone up 16.9. Below are key valuation metrics over time for VIVO.
Is VIVO a good buy?
Is Meridian Bioscience a good investment?
Is Meridian Bioscience a good company?
Is Meridian Bioscience a buy right now?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Meridian Bioscience in the last year. There are currently 1 buy rating for...
How has Meridian Bioscience's stock price been impacted by Coronavirus?
Meridian Bioscience's stock was trading at $6.43 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organiz...
Are investors shorting Meridian Bioscience?
Meridian Bioscience saw a increase in short interest in January. As of January 31st, there was short interest totaling 2,800,000 shares, an increas...
When is Meridian Bioscience's next earnings date?
Meridian Bioscience is scheduled to release its next quarterly earnings announcement on Friday, May 6th 2022. View our earnings forecast for Merid...
How were Meridian Bioscience's earnings last quarter?
Meridian Bioscience, Inc. (NASDAQ:VIVO) posted its quarterly earnings results on Friday, February, 4th. The company reported $0.35 EPS for the quar...
What guidance has Meridian Bioscience issued on next quarter's earnings?
Meridian Bioscience issued an update on its FY 2022 earnings guidance on Monday, February, 21st. The company provided earnings per share (EPS) guid...
What price target have analysts set for VIVO?
1 equities research analysts have issued 12 month price objectives for Meridian Bioscience's shares. Their forecasts range from $30.00 to $30.00. O...
Who are Meridian Bioscience's key executives?
Meridian Bioscience's management team includes the following people: John Patrick Kenny , Chief Executive Officer & Executive Director Julie Smit...
What is Jack Kenny's approval rating as Meridian Bioscience's CEO?
7 employees have rated Meridian Bioscience CEO Jack Kenny on Glassdoor.com . Jack Kenny has an approval rating of 56% among Meridian Bioscience's...
Meridian Bioscience (NASDAQ:VIVO) stock performs better than its underlying earnings growth over last five years
Will Meridian Bioscience (VIVO) Gain on Rising Earnings Estimates?
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
Why Meridian Bioscience's Shares Are Rising Today?
Meridian Bioscience (VIVO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Meridian Bioscience (VIVO) Q1 Earnings and Revenues Surpass Estimates
View more earnings on VIVOSee more from BenzingaDelcath's Chemosat Hepatic Delivery System Shows Overall Response Rate Of 60.5% In Eye Cancer That Spreads To LiverValneva - Pfizer Choose Three-Dose Schedule For Lyme Vaccine Candidate Moving Forward© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Hgk Asset Management Inc Buys Fiserv Inc, Duke Energy Corp, Lockheed Martin Corp, Sells ..
Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 40% and 19.78%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Hussman Strategic Advisors, inc Buys Pfizer Inc, Regeneron Pharmaceuticals Inc, Invesco, Sells ..
Jersey City, NJ, based Investment company Hgk Asset Management Inc (Current Portfolio) buys Fiserv Inc, Duke Energy Corp, Lockheed Martin Corp, Healthpeak Properties Inc, Kyndryl Holdings Inc, sells Accenture PLC, Dominion Energy Inc, Welltower Inc, W.W.
Earnings Preview: Meridian Bioscience (VIVO) Q1 Earnings Expected to Decline
Investment company Hussman Strategic Advisors, inc (Current Portfolio) buys Pfizer Inc, Regeneron Pharmaceuticals Inc, Invesco, Dell Technologies Inc, Juniper Networks Inc, sells , Meridian Bioscience Inc, Triton International, Celanese Corp, C.H.
When will Meridian Bioscience release its earnings?
Meridian Bioscience (VIVO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What is the NASDAQ symbol for Meridian Bioscience?
Meridian Bioscience is scheduled to release its next quarterly earnings announcement on Friday, August 6th 2021. View our earnings forecast for Meridian Bioscience.
What is Meridian Bioscience's EPS for 2021?
Meridian Bioscience trades on the NASDAQ under the ticker symbol "VIVO."
Does Meridian Bioscience pay dividends?
Meridian Bioscience issued an update on its third quarter 2021 earnings guidance on Tuesday, July, 20th. The company provided EPS guidance of for the period. The company issued revenue guidance of $63.50 million-$63.50 million, compared to the consensus revenue estimate of $77.22 million.
Which stocks are similar to Vivo?
Meridian Bioscience does not currently pay a dividend.
Which stocks have the highest correlation with Vivo?
Stocks that are quantitatively similar to VIVO, based on their financial statements, market capitalization, and price volatility, are SUPN, SCL, IRBT, PLPC, and KVHI.
What is the strongest trending metric for Vivo?
CPRX, CHRS, and XTNT are the stocks whose asset turnover ratios are most correlated with VIVO.
